共 50 条
Genomic profiling of late-onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndrome
被引:3
|作者:
Ali, O. Hasan
[1
,2
,3
]
Yurchenko, A. A.
[4
]
Pavlova, O.
[5
]
Sartori, A.
[6
]
Bomze, D.
[2
]
Higgins, R.
[1
]
Ring, S. S.
[2
]
Hartmann, F.
[2
]
Buehler, D.
[7
]
Fritzsche, F. R.
[8
]
Jochum, W.
[9
]
Navarini, A. A.
[10
]
Kim, A.
[11
]
French, L. E.
[13
]
Dermitzakis, E.
[6
]
Christiano, A. M.
[11
,12
]
Hohl, D.
[5
]
Bickers, D. R.
[11
]
Nikolaev, S., I
[4
,14
]
Flatz, L.
[1
,2
,3
]
机构:
[1] Univ Hosp Zurich, Dept Dermatol, Zurich, Switzerland
[2] Kantonsspital St Gallen, Inst Immunobiol, St Gallen, Switzerland
[3] Kantonsspital St Gallen, Dept Dermatol Venerol & Allergol, St Gallen, Switzerland
[4] Univ Paris Saclay, Inserm U981, Gustave Roussy Canc Campus, Villejuif, France
[5] CHU Vaudois, Serv Dermatol & Venerol, Lausanne, Switzerland
[6] Univ Geneva, Dept Genet Med & Dev, Med Sch, Geneva, Switzerland
[7] Dermatol Gossau, Gossau, Switzerland
[8] PATHOdiagnost AG, Herisau, Switzerland
[9] Kantonsspital St Gallen, Inst Pathol, St Gallen, Switzerland
[10] Univ Hosp Basel, Dept Dermatol, Basel, Switzerland
[11] Columbia Univ, Dept Dermatol, Irving Med Ctr, New York, NY 10027 USA
[12] Columbia Univ, Dept Genet & Dev, Irving Med Ctr, New York, NY USA
[13] Ludwig Maximilian Univ Munich, Dept Dermatol & Allergol, Munich, Germany
[14] Univ Paris 07, St Louis Hosp, Paris, France
基金:
瑞士国家科学基金会;
关键词:
SKIN-CANCER;
MUTATIONS;
D O I:
10.1111/jdv.16767
中图分类号:
R75 [皮肤病学与性病学];
学科分类号:
100206 ;
摘要:
Background Nevoid basal cell carcinoma syndrome (NBCCS) is an autosomal dominant genetic disorder. It is commonly caused by mutations inPTCH1and chiefly characterized by multiple basal cell carcinomas (BCCs) developing prior to the age of 30 years. In rare cases, NBCCS presents with a late onset of BCC development. Objective To investigate BCC tumorigenesis in two brothers, who showed characteristic features of NBCCS but developed their first BCCs only after the age of 40 years. Two other siblings did not show signs of NBCCS. Results We obtained blood samples from four siblings and nine BCCs from the two brothers with NBCCS. Whole exome sequencing and RNA sequencing revealed loss of heterozygosity (LOH) ofPTCH1in eight out of nine tumours that consistently involved the same haplotype on chromosome 9. This haplotype contained a germinal splice site mutation inPTCH1(NM_001083605:exon9:c.763-6C>A). Analysis of germline DNA confirmed segregation of this mutation with the disease. All BCCs harboured additional somatic loss-of-function (LoF) mutations in the remainingPTCH1allele which are not typically seen in other cases of NBCCS. This suggests a hypomorphic nature of the germinalPTCH1mutation in this family. Furthermore, all BCCs had a similar tumour mutational burden compared to BCCs of unrelated NBCCS patients while harbouring a higher number of damagingPTCH1mutations. Conclusions Our data suggest that a sequence of three genetic hits leads to the late development of BCCs in two brothers with NBCCS: a hypomorphic germline mutation, followed by somatic LOH and additional mutations that completePTCH1inactivation. These genetic events are in line with the late occurrence of the first BCC and with the higher number of damagingPTCH1mutations compared to usual cases of NBCCS.
引用
收藏
页码:396 / 402
页数:7
相关论文